+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Targeted Oncology Therapeutics: Lung Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Lung Cancers

  • Report
  • October 2021
  • 82 Pages
  • Global
From
Pediatric Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pediatric Drugs and Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 292 Pages
  • Global
From
From
Rituximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Rituximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
US Biosimilar industry outlook to 2028 - Product Thumbnail Image

US Biosimilar industry outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Hairy Cell Leukemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Hairy Cell Leukemia Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 146 Pages
  • Global
From
Multiple Myeloma Drugs Market 2024-2028 - Product Thumbnail Image

Multiple Myeloma Drugs Market 2024-2028

  • Report
  • July 2024
  • 179 Pages
  • Global
From
Skin Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Skin Cancer Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 483 Pages
  • Global
From
From
Non-opioid Pain Treatment - Global Strategic Business Report - Product Thumbnail Image

Non-opioid Pain Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 480 Pages
  • Global
From
Loading Indicator